Seven pharmaceutical companies join academic researchers to speed TB drug discovery
6 July 2012 | By Abbott
Groundbreaking partnership that aims to speed the discovery of essential new treatments...
List view / Grid view
News
Lilly obtains six months U.S. pediatric exclusivity for Cymbalta®
6 July 2012 | By Eli Lilly and Company
Eli Lilly and Company has met the United States FDA requirements for pediatric exclusivity for Cymbalta®...
AstraZeneca completes sale of Aptium Oncology assets
6 July 2012 | By AstraZeneca
AstraZeneca has completed the previously indicated sale of the assets of its subsidiary, Aptium Oncology...
Boehringer Ingelheim announces changes to Board of Managing Directors
5 July 2012 | By Boehringer Ingelheim
Joachim Hasenmaier to lead new Board Division Consumer Healthcare and Animal Health...
Amgen completes acquisition of KAI Pharmaceuticals
5 July 2012 | By Amgen
Amgen has announced the completion of the acquisition of KAI Pharmaceuticals, a privately held company based in South San Francisco...
Biogen Idec and SOBI initiate global clinical trials of long-lasting hemophilia A and B product candidates in children
5 July 2012 | By Biogen Idec
Biogen Idec and SOBI announced the initiation of two global pediatric clinical trials...
Sanofi to divest its stake in the Yves Rocher Group
4 July 2012 | By Sanofi
"We are pleased to have been able to support the development of the Yves Rocher Group for about 40 years...”
up to data and CAMO Software partner to deliver industry-first solution for Quality by Design initiatives in the Life Science industry
CAMO Software & up to data have partnered...
Abbott receives FDA approval for Healon EndoCoat protective gel for cataract surgery
3 July 2012 | By Abbott
Abbott has expanded its Healon® family of ophthalmic viscosurgical devices (OVDs)...
Bio-Day, a technology seminar focused on Life Science
3 July 2012 | By HORIBA Scientific
HORIBA Scientific, organizes its first Technology Seminar focused on Life Sciences...
European Commission positive decision on flutiform®
3 July 2012 | By FTI Consulting
The European Commission has adopted a legally binding decision in favour of granting of marketing authorisations for flutiform®...
GlaxoSmithKline concludes previously announced agreement in principle to resolve multiple investigations with US Government and numerous states
2 July 2012 | By GlaxoSmithKline
Agreement reached with the US Government...
Lonza expands its XS Microbial Expression Technology™ Toolbox by adding new alternative host organisms
Lonza, a world leader in biopharmaceutical development technologies, announced today the addition of two new host organisms and their associated systems to its XS Technology™ Platform. The expanded XS Technology™ Toolbox addresses the diversity of microbially-derived proteins by providing complementary expression systems that quickly deliver simple, reliable, high yielding cGMP…
NovoPen® 5 wins the red dot Best of the Best design award
2 July 2012 | By Novo Nordisk
Novo Nordisk awarded the red dot Best of the Best prize for its next-generation insulin injection pen, the NovoPen® 5...
GSK and Theravance announce positive results from four pivotal phase III studies for once-daily LAMA/LABA (UMEC/VI) in COPD
2 July 2012 | By GlaxoSmithKline
Results from the pivotal efficacy studies...
